OPTASE- glycerin solution/ drops 
Scope Health Inc

----------

Optase MGD Advanced Dry Eye Drops

Glycerin 0.9%

Keep Out of Reach of Children

If swallowed, get medical help or contact a poison control center right away.

Eye Lubricant

Warning
• For external use only.
• To avoid contamination, do not touch tip
of container to any surface. After use, shake the bottle
downwards in order to remove any residual drop that
may be left. Replace cap after using.
• Do not use the solution if it changes color or becomes
cloudy
Stop use and ask doctor if
• You feel eye pain.
• Changes in vision occur.
• Redness or irritation of the eye lasts.
• Condition worsens or lasts more than 72 hours.

Uses

• For use as a lubricant to prevent further irritation.
• May be used as a protectant against further irritation.
• To relieve dryness of the eye.

Directions
Put one or two drops in the affected eyes as needed.

Citric Acid Monohydrate, Polyoxyethylenesorbitan Monooleate, Potassium Chloride, Purified Water, Saccha Inchi Seed Oil, Sodium Hyaluronate , Sorbitan Monooleate, Trehalose, Tromethamine

Patient Information

Optase

OPTASE 
glycerin solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72972-004
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN9 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
TREHALOSE (UNII: B8WCK70T7I)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
WATER (UNII: 059QF0KO0R)  
TROMETHAMINE (UNII: 023C2WHX2V)  
SORBITAN MONOOLEATE (UNII: 06XEA2VD56)  
POTASSIUM CHLORIDE (UNII: 660YQ98I10)  
PLUKENETIA VOLUBILIS SEED OIL (UNII: 8ED72Z8J1Z)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72972-004-011 in 1 BOX02/22/2022
110 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01802/22/2022
Labeler - Scope Health Inc (116778693)
Registrant - Oy Finnsusp Ab (369374137)

Revised: 11/2023
Document Id: 0a7b8f8b-115a-842d-e063-6394a90ae3c6
Set id: d81c1a4f-87b0-ee8c-e053-2995a90af9e5
Version: 3
Effective Time: 20231119
 
Scope Health Inc